Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study
2016 ◽
Vol 174
(1-3)
◽
pp. 126-131
◽
Keyword(s):
Phase 3
◽